Literature DB >> 35554565

What can metabolites tell us about gliomas?

Oltea Sampetrean1, Hideyuki Saya2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35554565      PMCID： PMC9435489          DOI： 10.1093/neuonc/noac128

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  8 in total

Review 1.  Metabolomics: A Primer.

Authors:  Xiaojing Liu; Jason W Locasale
Journal:  Trends Biochem Sci       Date:  2017-02-11       Impact factor: 13.807

2.  Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.

Authors:  Gary Kohanbash; Diego A Carrera; Shruti Shrivastav; Brian J Ahn; Naznin Jahan; Tali Mazor; Zinal S Chheda; Kira M Downey; Payal B Watchmaker; Casey Beppler; Rolf Warta; Nduka A Amankulor; Christel Herold-Mende; Joseph F Costello; Hideho Okada
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

Review 3.  Understanding the Intersections between Metabolism and Cancer Biology.

Authors:  Matthew G Vander Heiden; Ralph J DeBerardinis
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

4.  Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate.

Authors:  Lukas Bunse; Stefan Pusch; Theresa Bunse; Felix Sahm; Khwab Sanghvi; Mirco Friedrich; Dalia Alansary; Jana K Sonner; Edward Green; Katrin Deumelandt; Michael Kilian; Cyril Neftel; Stefanie Uhlig; Tobias Kessler; Anna von Landenberg; Anna S Berghoff; Kelly Marsh; Mya Steadman; Dongwei Zhu; Brandon Nicolay; Benedikt Wiestler; Michael O Breckwoldt; Ruslan Al-Ali; Simone Karcher-Bausch; Matthias Bozza; Iris Oezen; Magdalena Kramer; Jochen Meyer; Antje Habel; Jessica Eisel; Gernot Poschet; Michael Weller; Matthias Preusser; Minou Nadji-Ohl; Niklas Thon; Michael C Burger; Patrick N Harter; Miriam Ratliff; Richard Harbottle; Axel Benner; Daniel Schrimpf; Jürgen Okun; Christel Herold-Mende; Sevin Turcan; Stefan Kaulfuss; Holger Hess-Stumpp; Karen Bieback; Daniel P Cahill; Karl H Plate; Daniel Hänggi; Marion Dorsch; Mario L Suvà; Barbara A Niemeyer; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nat Med       Date:  2018-07-09       Impact factor: 53.440

Review 5.  Hallmarks of Cancer: New Dimensions.

Authors:  Douglas Hanahan
Journal:  Cancer Discov       Date:  2022-01       Impact factor: 39.397

6.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors:  Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal:  Nature       Date:  2009-12-10       Impact factor: 49.962

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

8.  Distinct metabolic hallmarks of WHO classified adult glioma subtypes.

Authors:  Benny Björkblom; Carl Wibom; Maria Eriksson; A Tommy Bergenheim; Rickard L Sjöberg; Pär Jonsson; Thomas Brännström; Henrik Antti; Maria Sandström; Beatrice Melin
Journal:  Neuro Oncol       Date:  2022-09-01       Impact factor: 13.029
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.